[The nicotinamide-phosphoribosiltransferase as a marker of systemic inflammation under osteoarthrosis.]
Autor: | Akhverdyan YR; The research institute of clinical and experimental rheumatology, 400138, Volgograd, Russia., Zavodovsky BV; The research institute of clinical and experimental rheumatology, 400138, Volgograd, Russia., Polyakova YV; The research institute of clinical and experimental rheumatology, 400138, Volgograd, Russia., Sivordova LE; The research institute of clinical and experimental rheumatology, 400138, Volgograd, Russia., Zborovskaya IA; The research institute of clinical and experimental rheumatology, 400138, Volgograd, Russia. |
---|---|
Jazyk: | ruština |
Zdroj: | Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2017; Vol. 62 (10), pp. 606-610. |
DOI: | 10.18821/0869-2084-2017-62-10-606-610 |
Abstrakt: | The purpose of study is to establish the level of visfatin (Nampt, nicotinamide-phosphoribosiltransferase) in blood serum of healthy volunteers for determination of the level of normal values of of the given parameter specific to healthy people. Besides, the given parameter also was analyzed in patients with osteoarthritis. The sampling consisted of 152 individuals. Out of them, 92 patients with primary osteoarthritis and 60 healthy individuals. The level of Nampt in blood serum of healthy people was detected by using commercial test-systems (RaiBiotech, cat. № EIA-VIS-1). The average level of Nampt in blood serum of healthy people made up to 2,43±0,17 ng/ml (M ± m). The level of normal values of Nampt in healthy people detected as М ± 2σ, made up to from 0 to 5.07 ng/ml. The study data proved the relationship between concentration of Nampt ans expression of clinical manifestations of osteoarthritis. It is demonstrated that higher level of Nampt in blood serum was typical for patients with more severe clinical course of disease. The obtained data testify that high level of Nampt correlates positively with higher concentrations of C-reactive protein and ESR that indirectly testifies in behalf of anti-inflammatory character of action of Nampt and substantiates hypothesis about primary role of systemic inflammation in pathogenesis of osteoarthritis. Competing Interests: The authors declare no conflict of interest. |
Databáze: | MEDLINE |
Externí odkaz: |